Prescribing Red Flags and Suspicious Controlled Substance Orders: Current Cautionary Tales
FDA Law
DECEMBER 4, 2023
Prescriptions Containing No Diagnosis or Intended Use Controlled substance prescriptions issued with a non-specific diagnosis or no diagnosis. On October 10th, based on ability to pay, the U.S. 11, 2023 ( DOJ Press Release ). Our post on the Betances distributor decision and suspicious orders will appear in the near future.
Let's personalize your content